Alexion Pharmaceuticals Inc. shares dropped from 0.32% to $179.45 Monday.This proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 1.59% to 4,258.49 and Dow Jones Industrial Average DJIA falling 2.09% to 33,962.04.
Alexion Pharmaceuticals Inc. closed $8.00 short of its 52-week high ($187.45), which the company reached on July 14th.Compared to some of its competitors on Monday, the stock demonstrated mixed performance as Gilead Sciences Inc. GILD fell 0.58% to $68.23, Vertex Pharmaceuticals Inc. VRTX fell 1.50% to $199.24, and Regeneron Pharmaceuticals Inc. REGN rose 0.34% to $585.23.
ALXN, at last check, was trading at a discount to its 52-week high of $187.45, offering almost -3.35% off that amount. The share price’s 52-week low was $99.91, which indicates that the recent value has risen by an impressive 44.92% since then. Alexion Pharmaceuticals Inc.’s average daily trading volume that its 10-day average is 6.27 million shares, with the 3-month average coming to 2.64 million.As assigned by Wall Street analysts, the consensus price target is $179.20, which translates to bulls needing to decrease their stock price by -1.22% from its current value.